RxDoctor Payments Data

Lourdes Esteban

Neurology · Brooklyn, NYNPI 1821022856

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,331 of the $1,489 with a category attached, or 89.4%. It is spread thinly across 20 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $513 and has fallen 93.3% since, to $34 in 2025.

$1,489in general payments, 2019–2025

Across 74 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$290
  • UCB, Inc.$174
  • Acorda Therapeutics, Inc$158
  • Biogen$142
  • Lilly USA, LLC$116
  • Novartis$95
  • plus $514 from 14 others

What the payments were for

  • Speaking & faculty fees$15811%
  • Food & beverage$1,33189%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,489 in reported general payments places this provider in the 55th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Other neurology in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →